Serious adverse events possibly related to study treatment. Both events were considered to be possibly related to ziv‐aflibercept (unlikely to be related to ganetespib).
Abbreviation: NOS, not otherwise specified.
Serious adverse events possibly related to study treatment. Both events were considered to be possibly related to ziv‐aflibercept (unlikely to be related to ganetespib).
Abbreviation: NOS, not otherwise specified.